拉通过清理烯蛋白来缓解噪音引起的听力损失
Chaoyong Tian1, Yao Li1, Yang Yang1
1Department of Otolaryngology Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an, Shannxi Province 710032, China.
Neuroscience letters
|November 4, 2024
概括
氨酸是一种氨酸清理剂,有效治疗大鼠的噪音引起的听力损失 (NIHL). 这项研究表明,阿克罗莱因有助于NIHL和质细胞激活,突出了其作为治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 毒理学 毒理学 毒理学
背景情况:
- 噪音引起的听力损失 (NIHL) 是一种普遍存在的听力损失形式.
- 阿克罗莱因已与NIHL的病变产生有关.
- 质细胞激活是耳对噪音损伤反应的关键特征.
研究的目的:
- 为NIHL研究氨酸的治疗潜力,一个氨酸清除剂.
- 阐明阿克罗莱因在噪音诱导的耳损伤和质细胞激活中的作用.
- 评估拉治疗对大鼠模型中的听觉功能和分子标记物的影响.
主要方法:
- 建立了NIHL的老鼠模型,使用10kHz纯色调暴露.
- 通过听觉脑干响应 (ABR) 测试和扫描电子显微镜评估听觉功能.
- 通过免疫光学,qRT-PCR和西部涂抹,评估了阿克罗莱因,GFAP,OX42,IL-18,IL-1β和FTK表达.
主要成果:
- 噪音暴露成功诱导了NIHL,其特点是ABR值升高.
- 在噪音暴露后的耳核中观察到烯蛋白,GFAP,OX42,FTK,IL-1β和IL-18的表达增加.
- 拉治疗逆转了噪音引起的变化,减轻了NIHL和acrolein的影响.
结论:
- 阿克罗林在噪音引起的听力损失和相关的质细胞激活中起着重要作用.
- 海德拉因通过向阿克罗莱因,证明了对NIHL的治疗疗效.
- 阿克罗莱因代表了一种有前途的治疗标,用于管理噪音引起的听力损失.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
482
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
482
01:22Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
590
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
590
01:25Antihypertensive Drugs: Direct Renin Inhibitors
498
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
498
01:23Antihypertensive Drugs: Vasodilators
481
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
481